2020年度発表論文等一覧

原著論文－英文

1. Yamada Y, Muro K, Takahashi K, Baba H, Komatsu Y, Satoh T, Goto M, Mishima H, Watanabe M, Sakata Y, Morita S, Shimada Y, Takenaka N, Hirooka T, Sugihara K.
   Impact of sex and histology on the therapeutic effects of fluoropyrimidines and oxaliplatin plus bevacizumab for patients with metastatic colorectal cancer in the SOFT trial.
   Global Health & Medicine 2:240-246, 2020.
2. Iwasa S, Okita N, Kuchiba A, Ogawa G, Kawasaki M, Nakamura K, Shoji H, Honma Y, Takashima A, Kato K, Hamaguchi T, Boku N, Yamada Y.
   Phase II study of lenvatinib for metastatic colorectal cancer refractory to standard chemotherapy: the LEMON study (NCCH1503).
   ESMO Open: 5, e000776, 2020. (IF:5.329)
3. Yamada Y, Koizumi W, Nishikawa K, Gotoh M, Fuse N, Sugimoto N, Nishina T, Amagai K, Chin K, Niwa Y, Tsuji A, Imamura H, Tsuda M, Yasui H, Fujii H, Yamaguchi K, Yasui H, Hironaka S, Shimada K, Hyodo I.
   Sex differences in safety of S-1 plus oxaliplatin and S-1 plus cisplatin for patients with metastatic gastric cancer.
   Cancer Sci 110: 2875-2883, 2019. (IF: 6.716)
4. Matsuyama T, Kandimalla R, Ishikawa T, Takahashi N, Yamada Y, Yasuno M, Kinugasa Y, Hansen TF, Fakih M, Uetake H, Győrffy B, Goel A.
   A novel mesenchymal-associated transcriptomic signature for risk-stratification and therapeutic response prediction in colorectal cancer.
   Int J Cancer 147: 3250-3261, 2020. (IF: 7.396)

原著論文－和文

1. Hashimoto H, Iwasa S, Yanai-Takahashi T, Honma Y, Kato K, Hamaguchi T, Yamada Y, Shimada Y, Yamazaki N, Kato Y.
   Randomized, Double-Blind, Placebo-Controlled Phase Ⅱ Study on the Efficacy and Safety of Vitamin K1 Ointment for Cetuximab or Panitumumab-Induced Acneiform Eruptions-VIKTORIA Study.
   Gan To Kagaku Ryoho 47:933.75239, 2020.

著書・総説

総説論文・欧文

1. Yamada Y.
   Present status and perspective of chemotherapy for patients with unresectable advanced or metastatic gastric cancer in Japan.
   Global Health & Medicine 2:156-163, 2020.